BACKGROUND: We report the findings from 4437 individuals (3219 patients and 1218 relatives) who have been analyzed by whole genome sequencing (WGS) at the Genomic Medicine Center Karolinska-Rare Diseases (GMCK-RD) since mid-2015. GMCK-RD represents a long-term collaborative initiative between Karolinska University Hospital and Science for Life Laboratory to establish advanced, genomics-based diagnostics in the Stockholm healthcare setting. METHODS: Our analysis covers detection and interpretation of SNVs, INDELs, uniparental disomy, CNVs, balanced structural variants, and short tandem repeat expansions. Visualization of results for clinical interpretation is carried out in Scout-a custom-developed decision support system. Results from both singleton (84%) and trio/family (16%) analyses are reported. Variant interpretation is done by 15 expert teams at the hospital involving staff from three clinics. For patients with complex phenotypes, data is shared between the teams. RESULTS: Overall, 40% of the patients received a molecular diagnosis ranging from 19 to 54% for specific disease groups. There was heterogeneity regarding causative genes (n = 754) with some of the most common ones being COL2A1 (n = 12; skeletal dysplasia), SCN1A (n = 8; epilepsy), and TNFRSF13B (n = 4; inborn errors of immunity). Some causative variants were recurrent, including previously known founder mutations, some novel mutations, and recurrent de novo mutations. Overall, GMCK-RD has resulted in a large number of patients receiving specific molecular diagnoses. Furthermore, negative cases have been included in research studies that have resulted in the discovery of 17 published, novel disease-causing genes. To facilitate the discovery of new disease genes, GMCK-RD has joined international data sharing initiatives, including ClinVar, UDNI, Beacon, and MatchMaker Exchange. CONCLUSIONS: Clinical WGS at GMCK-RD has provided molecular diagnoses to over 1200 individuals with a broad range of rare diseases. Consolidation and spread of this clinical-academic partnership will enable large-scale national collaboration.
BACKGROUND: We report the findings from 4437 individuals (3219 patients and 1218 relatives) who have been analyzed by whole genome sequencing (WGS) at the Genomic Medicine Center Karolinska-Rare Diseases (GMCK-RD) since mid-2015. GMCK-RD represents a long-term collaborative initiative between Karolinska University Hospital and Science for Life Laboratory to establish advanced, genomics-based diagnostics in the Stockholm healthcare setting. METHODS: Our analysis covers detection and interpretation of SNVs, INDELs, uniparental disomy, CNVs, balanced structural variants, and short tandem repeat expansions. Visualization of results for clinical interpretation is carried out in Scout-a custom-developed decision support system. Results from both singleton (84%) and trio/family (16%) analyses are reported. Variant interpretation is done by 15 expert teams at the hospital involving staff from three clinics. For patients with complex phenotypes, data is shared between the teams. RESULTS: Overall, 40% of the patients received a molecular diagnosis ranging from 19 to 54% for specific disease groups. There was heterogeneity regarding causative genes (n = 754) with some of the most common ones being COL2A1 (n = 12; skeletal dysplasia), SCN1A (n = 8; epilepsy), and TNFRSF13B (n = 4; inborn errors of immunity). Some causative variants were recurrent, including previously known founder mutations, some novel mutations, and recurrent de novo mutations. Overall, GMCK-RD has resulted in a large number of patients receiving specific molecular diagnoses. Furthermore, negative cases have been included in research studies that have resulted in the discovery of 17 published, novel disease-causing genes. To facilitate the discovery of new disease genes, GMCK-RD has joined international data sharing initiatives, including ClinVar, UDNI, Beacon, and MatchMaker Exchange. CONCLUSIONS: Clinical WGS at GMCK-RD has provided molecular diagnoses to over 1200 individuals with a broad range of rare diseases. Consolidation and spread of this clinical-academic partnership will enable large-scale national collaboration.
Authors: Amalio Telenti; Levi C T Pierce; William H Biggs; Julia di Iulio; Emily H M Wong; Martin M Fabani; Ewen F Kirkness; Ahmed Moustafa; Naisha Shah; Chao Xie; Suzanne C Brewerton; Nadeem Bulsara; Chad Garner; Gary Metzker; Efren Sandoval; Brad A Perkins; Franz J Och; Yaron Turpaz; J Craig Venter Journal: Proc Natl Acad Sci U S A Date: 2016-10-04 Impact factor: 11.205
Authors: Magnus K Bjursell; Henk J Blom; Jordi Asin Cayuela; Martin L Engvall; Nicole Lesko; Shanti Balasubramaniam; Göran Brandberg; Maria Halldin; Maria Falkenberg; Cornelis Jakobs; Desiree Smith; Eduard Struys; Ulrika von Döbeln; Claes M Gustafsson; Joakim Lundeberg; Anna Wedell Journal: Am J Hum Genet Date: 2011-09-28 Impact factor: 11.025
Authors: Ernest Turro; William J Astle; Karyn Megy; Stefan Gräf; Daniel Greene; Olga Shamardina; Hana Lango Allen; Alba Sanchis-Juan; Mattia Frontini; Chantal Thys; Jonathan Stephens; Rutendo Mapeta; Oliver S Burren; Kate Downes; Matthias Haimel; Salih Tuna; Sri V V Deevi; Timothy J Aitman; David L Bennett; Paul Calleja; Keren Carss; Mark J Caulfield; Patrick F Chinnery; Peter H Dixon; Daniel P Gale; Roger James; Ania Koziell; Michael A Laffan; Adam P Levine; Eamonn R Maher; Hugh S Markus; Joannella Morales; Nicholas W Morrell; Andrew D Mumford; Elizabeth Ormondroyd; Stuart Rankin; Augusto Rendon; Sylvia Richardson; Irene Roberts; Noemi B A Roy; Moin A Saleem; Kenneth G C Smith; Hannah Stark; Rhea Y Y Tan; Andreas C Themistocleous; Adrian J Thrasher; Hugh Watkins; Andrew R Webster; Martin R Wilkins; Catherine Williamson; James Whitworth; Sean Humphray; David R Bentley; Nathalie Kingston; Neil Walker; John R Bradley; Sofie Ashford; Christopher J Penkett; Kathleen Freson; Kathleen E Stirrups; F Lucy Raymond; Willem H Ouwehand Journal: Nature Date: 2020-06-24 Impact factor: 49.962
Authors: Christopher C Chang; Carson C Chow; Laurent Cam Tellier; Shashaank Vattikuti; Shaun M Purcell; James J Lee Journal: Gigascience Date: 2015-02-25 Impact factor: 6.524
Authors: Tobias Laurell; Daniel Nilsson; Wolfgang Hofmeister; Anna Lindstrand; Nadav Ahituv; Julia Vandermeer; Anders Amilon; Göran Annerén; Marianne Arner; Maria Pettersson; Nina Jäntti; Hans-Eric Rosberg; Peter A Cattini; Agneta Nordenskjöld; Outi Mäkitie; Giedre Grigelioniene; Ann Nordgren Journal: Mol Genet Genomic Med Date: 2014-05-14 Impact factor: 2.183
Authors: Anna Lindstrand; Jesper Eisfeldt; Maria Pettersson; Claudia M B Carvalho; Malin Kvarnung; Giedre Grigelioniene; Britt-Marie Anderlid; Olof Bjerin; Peter Gustavsson; Anna Hammarsjö; Patrik Georgii-Hemming; Erik Iwarsson; Maria Johansson-Soller; Kristina Lagerstedt-Robinson; Agne Lieden; Måns Magnusson; Marcel Martin; Helena Malmgren; Magnus Nordenskjöld; Ameli Norling; Ellika Sahlin; Henrik Stranneheim; Emma Tham; Josephine Wincent; Sofia Ygberg; Anna Wedell; Valtteri Wirta; Ann Nordgren; Johanna Lundin; Daniel Nilsson Journal: Genome Med Date: 2019-11-07 Impact factor: 11.117
Authors: Yin-Huai Chen; Giedre Grigelioniene; Phillip T Newton; Jacob Gullander; Maria Elfving; Anna Hammarsjö; Dominyka Batkovskyte; Hessa S Alsaif; Wesam I Y Kurdi; Firdous Abdulwahab; Veerabahu Shanmugasundaram; Luke Devey; Séverine Bacrot; Jana Brodszki; Celine Huber; Ben Hamel; David Gisselsson; Nikos Papadogiannakis; Katarina Jedrycha; Barbara Gürtl-Lackner; Andrei S Chagin; Gen Nishimura; Dominik Aschenbrenner; Fowzan S Alkuraya; Arian Laurence; Valérie Cormier-Daire; Holm H Uhlig Journal: J Exp Med Date: 2020-03-02 Impact factor: 14.307
Authors: Yoshihito Kishita; Aleksandra Pajak; Nikhita Ajit Bolar; Carlo M T Marobbio; Camilla Maffezzini; Daniela V Miniero; Magnus Monné; Masakazu Kohda; Henrik Stranneheim; Kei Murayama; Karin Naess; Nicole Lesko; Helene Bruhn; Arnaud Mourier; Rolf Wibom; Inger Nennesmo; Ann Jespers; Paul Govaert; Akira Ohtake; Lut Van Laer; Bart L Loeys; Christoph Freyer; Ferdinando Palmieri; Anna Wredenberg; Yasushi Okazaki; Anna Wedell Journal: Am J Hum Genet Date: 2015-10-29 Impact factor: 11.025
Authors: Giedre Grigelioniene; Hiroshi I Suzuki; Fulya Taylan; Fatemeh Mirzamohammadi; Zvi U Borochowitz; Ugur M Ayturk; Shay Tzur; Eva Horemuzova; Anna Lindstrand; Mary Ann Weis; Gintautas Grigelionis; Anna Hammarsjö; Elin Marsk; Ann Nordgren; Magnus Nordenskjöld; David R Eyre; Matthew L Warman; Gen Nishimura; Phillip A Sharp; Tatsuya Kobayashi Journal: Nat Med Date: 2019-02-25 Impact factor: 53.440
Authors: Kandamurugu Manickam; Monica R McClain; Laurie A Demmer; Sawona Biswas; Hutton M Kearney; Jennifer Malinowski; Lauren J Massingham; Danny Miller; Timothy W Yu; Fuki M Hisama Journal: Genet Med Date: 2021-07-01 Impact factor: 8.822
Authors: Katherine R Schon; Rita Horvath; Wei Wei; Claudia Calabrese; Arianna Tucci; Kristina Ibañez; Thiloka Ratnaike; Robert D S Pitceathly; Enrico Bugiardini; Rosaline Quinlivan; Michael G Hanna; Emma Clement; Emma Ashton; John A Sayer; Paul Brennan; Dragana Josifova; Louise Izatt; Carl Fratter; Victoria Nesbitt; Timothy Barrett; Dominic J McMullen; Audrey Smith; Charulata Deshpande; Sarah F Smithson; Richard Festenstein; Natalie Canham; Mark Caulfield; Henry Houlden; Shamima Rahman; Patrick F Chinnery Journal: BMJ Date: 2021-11-03